Pre-market oversold bounce: 3141.T Welcia Holdings (JPX) at JPY 3160.00 — watch volume and key resistance

The 3141.T stock opened pre-market at JPY 3,300.00 and trades at JPY 3,160.00, down ¥93.00 (-2.86%), but with very high volume (7,780,300.00) that signals a possible oversold bounce. This setup matters because price sits above the 50-day average JPY 2,929.49 and far above the 200-day average JPY 2,579.99, creating a technical pullback opportunity on JPX. We outline precise entry and stop levels, compare valuation metrics, and show how Meyka AI’s model frames short-term and model-driven forecasts for Welcia Holdings Co., Ltd.

Pre-market snapshot: 3141.T stock key figures

Price is JPY 3,160.00 with a session range JPY 3,000.00–JPY 3,345.00 and previous close JPY 3,253.00. Volume is 7,780,300.00 versus average volume 648,065.00, giving a relative volume of ~12.01. Market cap stands at JPY 655,965,433,680.00 on the JPX market in Japan.

Why the oversold bounce setup matters for 3141.T stock

Heavy trading on a down move shows short-term exhaustion and creates a bounce candidate. The wide intraday range and spike in volume raise the odds of a mean-reversion move back toward near resistance at JPY 3,345.00. For traders using oversold bounce rules, the combination of high relative volume and proximity to the 50-day average is the trigger signal.

Fundamentals and valuation for 3141.T stock

Welcia Holdings reports EPS ¥92.27 and a trailing PE of 34.25, above the Healthcare sector average PE ~23.91, reflecting premium valuation. Price-to-book sits at 2.51 and price-to-sales at 0.49, while dividend yield is 1.14%. Note operating cash flow per share is negative at -¥113.42, which raises cash-flow risk despite solid earnings.

Meyka AI rates and technical trade plan for 3141.T stock

Meyka AI rates 3141.T with a score out of 100: 74.16 (B+) — Suggestion: BUY. This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst signals. For an oversold bounce trade we propose a clear plan: entry JPY 3,080.00–JPY 3,160.00, stop below JPY 2,930.00, first target JPY 3,300.00, stretch target JPY 3,345.00. Keep position size limited and use a tight stop because cash-flow metrics are mixed.

Sector context and 3141.T stock relative performance

Healthcare sector average PE is ~23.91 and average net margin ~10.17%; Welcia’s net margin is lower but stable. Retail pharmacy demand in Japan remains defensive, which supports revenue resilience. Compare Welcia to peers on JPX when judging valuation and competitive trends.

Catalysts, risks and watchlist items for 3141.T stock

Catalysts include stronger same-store sales, improved operating cash flow, and any favorable pricing or pharmacy regulation updates. Risks include negative operating cash flow per share -¥113.42, rising SG&A, and premium PE that compresses if earnings slow. Monitor volume, intraday VWAP, and news feeds such as historical price updates Investing.com and our internal Meyka stock page for live signals: Meyka 3141.T page.

Final Thoughts

Short-term traders should treat 3141.T stock as a controlled oversold-bounce candidate in pre-market. The stock trades at JPY 3,160.00 on JPX with unusually high volume, which supports a mean-reversion trade toward initial resistance JPY 3,300.00 and the year high JPY 3,345.00 if buyers re-enter. Fundamental checks show EPS ¥92.27 but a higher PE 34.25 and negative operating cash flow per share -¥113.42, so any rebound should be sized modestly and monitored closely. Meyka AI’s forecast model projects JPY 1,709.43 (yearly horizon), implying -45.94% versus the current price JPY 3,160.00; forecasts are model-based projections and not guarantees. Use the suggested entry JPY 3,080.00–JPY 3,160.00, stop below JPY 2,930.00, and scale out at JPY 3,300.00–JPY 3,345.00. We mention Meyka AI as an AI-powered market analysis platform to note that grade and forecasts come from our models; always match trade size to your risk profile.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.